Desq Long
Sign in

Company

Edwards Lifesciences Corp

EW · CIK 0001099800

SEC FORM 4
$47,922.16

Edwards Lifesciences Corp (EW)

Disposition (code F) of 568 shares at $84.3700 per share.

Reporting Person Markowitz Wayne · Officer Title CVP, JAPAC · Transaction Code F

Traded Sep 14, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001225208-26-007812 · filed 2026-09-14 · View filing →

SEC FORM 4
$21,345.61

Edwards Lifesciences Corp (EW)

Disposition (code F) of 253 shares at $84.3700 per share.

Reporting Person Dahl Andrew M. · Officer Title SVP, Corporate Controller · Transaction Code F

Traded Sep 13, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001225208-26-007811 · filed 2026-09-14 · View filing →

SEC FORM 4
$30,803.35

Edwards Lifesciences Corp (EW)

Disposition (code F) of 355 shares at $86.7700 per share.

Reporting Person Markowitz Wayne · Officer Title CVP, JAPAC · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001225208-26-007812 · filed 2026-09-14 · View filing →

SEC FORM 4
$44,988.92

Edwards Lifesciences Corp (EW)

Acquisition (code M) of 619 shares at $72.6800 per share.

Reporting Person Lippis Daniel J. · Officer Title CVP, TAVR · Transaction Code M

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001225208-26-007774 · filed 2026-09-11 · View filing →

SEC FORM 4
$54,168.69

Edwards Lifesciences Corp (EW)

Sale of 619 shares at $87.5100 per share.

Reporting Person Lippis Daniel J. · Officer Title CVP, TAVR · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001225208-26-007774 · filed 2026-09-11 · View filing →

SEC FORM 4
$34,534.46

Edwards Lifesciences Corp (EW)

Disposition (code F) of 398 shares at $86.7700 per share.

Reporting Person Chopra Daveen · Officer Title CVP, TMTT, Surgical & IHFM · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001225208-26-007775 · filed 2026-09-11 · View filing →

SEC FORM 4
$49,533.92

Edwards Lifesciences Corp (EW)

Sale of 544 shares at $91.0550 per share.

Reporting Person Dahl Andrew M. · Officer Title SVP, Corporate Controller · Transaction Code S

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001225208-26-007408 · filed 2026-08-31 · View filing →

SEC FORM 4
$237,907.12

Edwards Lifesciences Corp (EW)

Sale of 2,644 shares at $89.9800 per share.

Reporting Person Bruls Annette · Officer Title CVP, EMEACLA · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001225208-26-007377 · filed 2026-08-28 · View filing →

SEC FORM 4
$113,416.60

Edwards Lifesciences Corp (EW)

Sale of 1,240 shares at $91.4650 per share.

Reporting Person Markowitz Wayne · Officer Title CVP, JAPAC · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001225208-26-007332 · filed 2026-08-26 · View filing →

SEC FORM 4
$2,311,224.00

Edwards Lifesciences Corp (EW)

Acquisition (code M) of 31,800 shares at $72.6800 per share.

Reporting Person Chopra Daveen · Officer Title CVP, TMTT, Surgical & IHFM · Transaction Code M

Traded Aug 26, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001225208-26-007335 · filed 2026-08-26 · View filing →

SEC FORM 4
$105,892.66

Edwards Lifesciences Corp (EW)

Sale of 1,154 shares at $91.7614 per share.

Reporting Person Chopra Daveen · Officer Title CVP, TMTT, Surgical & IHFM · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001225208-26-007335 · filed 2026-08-26 · View filing →

SEC FORM 4
$2,788,546.96

Edwards Lifesciences Corp (EW)

Sale of 30,646 shares at $90.9922 per share.

Reporting Person Chopra Daveen · Officer Title CVP, TMTT, Surgical & IHFM · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001225208-26-007335 · filed 2026-08-26 · View filing →

STOCK ACT PTR
$1,001 - $15,000

Edwards Lifesciences Corp (EW)

Purchase.

Filer Ro Khanna · Chamber House · District CA17 · Transaction Type Purchase · Asset Type Stock

Traded May 1, 2026 · Disclosed Jun 9, 2026FILED +39 DAYS

Source: House Clerk PTR · 9116142 · filed 2026-06-09 · View filing →